After years of adulation, the stock market has soured on private-credit fund managers. Investors have also had second thoughts about the billions of dollars spent on artificial intelligence data ...
Shares of Target climbed Friday after the Financial Times reported that hedge fund Toms Capital Investment Management has made a “significant investment” in the big-box retailer, whose sales and share ...
AmericaFest honors Target employee Jeanie Beeman after viral video shows calm response to harassment
Turning Point USA honored a Target employee who went viral after a customer accosted her for wearing a Charlie Kirk shirt to work this weekend. Jeanie Beeman, 72, received a flood of support from ...
Micron Technology, Inc. (NASDAQ:MU) is one of the AI Stocks on the Market’s Radar. On December 18, Rosenblatt raised its price target on the stock to $500 from $300 on Thursday, maintaining a Buy ...
Target Corp.’s online operations have stabilized after a technology outage disrupted the retailer’s digital order pickup, returns and other functions during the all-important holiday period. “As of ...
Target was experiencing issues with its online system just a week before Christmas and Kwanzaa 2025 and amid Hanukkah celebrations. Outage reports for the nationwide retailer started to roll in at ...
There have been multiple iterations of Willy Wonka over the years, but my overall favorite is still the original. Gene Wilder was able to capture the perfect mix of madness and magic in a way that no ...
PepsiCo, Inc. (NASDAQ:PEP) is included among the 15 Best Blue-Chip Stocks with Growing Dividends. On December 11, Barclays raised its price target on PepsiCo, Inc. (NASDAQ:PEP) to $144 from $142, ...
I shopped for Christmas gifts for my husband and teenagers at Walmart and Target. Prices seemed similar at both chains, but Target had more sales and a better overall holiday vibe. I like Walmart, but ...
Target faced significant sales and reputation declines after rolling back DEI policies and controversial Pride Month displays, leading to widespread boycotts and a 30% stock drop. However, RepTrak ...
The U.S. Food and Drug Administration on Monday awarded a national priority voucher to Johnson & Johnson’s (NYSE: JNJ) Tecvayli (teclistamab) in combination with daratumumab for relapsed/refractory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback